Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
P01 ANTIPROTOZOALS
P01C AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS
P01CA Nitroimidazole derivatives
P01CA03 Fexinidazole
D11252 Fexinidazole (USAN/INN) <US>
Drug groups [BR:br08330]
Antiparasitic
DG01884 Imidazole antiprotozoal
D11252 Fexinidazole
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D11252 Fexinidazole
Antimicrobials [BR:br08307]
Antiparasitics
Agents against Leishmaniasis and Trypanosomiasis
Nitroimidazole derivatives
D11252 Fexinidazole (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11252
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11252
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D11252
Other DBs
CAS:
59729-37-2
PubChem:
384585230
KCF data
ATOM 19
1 N5x N 19.5817 -19.4830
2 C8x C 20.0325 -20.8084
3 C8y C 21.4324 -20.7893
4 N4y N 21.8468 -19.4520
5 C8y C 20.7030 -18.6447
6 N2b N 22.1324 -22.0017 #+
7 O3a O 23.1223 -22.9917
8 O3a O 20.5700 -22.9817 #-
9 C1a C 23.1637 -19.0041
10 C1b C 20.7532 -17.2205
11 O2a O 21.9636 -16.5770
12 C8y C 21.9636 -15.1770
13 C8x C 23.1826 -14.4732
14 C8x C 23.1825 -13.0732
15 C8y C 21.9700 -12.3733
16 C8x C 20.7510 -13.0771
17 C8x C 20.7511 -14.4771
18 S2a S 21.9700 -10.9900
19 C1a C 23.1899 -10.2857
BOND 20
1 1 2 1
2 2 3 2
3 3 4 1
4 4 5 1
5 1 5 2
6 3 6 1
7 6 7 2
8 6 8 1
9 4 9 1
10 5 10 1
11 10 11 1
12 11 12 1
13 12 13 2
14 13 14 1
15 14 15 2
16 15 16 1
17 16 17 2
18 12 17 1
19 15 18 1
20 18 19 1